Skip to main content
. 2018 Dec 6;4(4):2055217318814562. doi: 10.1177/2055217318814562

Figure 1.

Figure 1.

Flow chart showing study population. The first set concerns the time between the first symptoms and diagnosis (1365 to 990) (column 2 in Table 1). The second set is the time between diagnosis and disease-modifying treatment start (1059 to 872) (column 3 in Table 1). CDMS: clinically definite multiple sclerosis.